These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 15585154
1. [Clearance effect of different blood purification techniques on parathyroid hormone in renal function failure patients on maintenance hemodialysis]. Wang C, Lou TQ, Tang H, Chen ZJ, Yin PD, Yu XQ. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):753-5. PubMed ID: 15585154 [Abstract] [Full Text] [Related]
2. Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness. Li X, Li M, Liu T, Li L, Duan L, Li Y, Yang G, Guo L. Chin Med J (Engl); 1997 Jul; 110(7):520-5. PubMed ID: 9594209 [Abstract] [Full Text] [Related]
3. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H, Baradaran A, Naderi AS. Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479 [Abstract] [Full Text] [Related]
4. Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure. Liu J, Liu ZQ, Tao HQ. Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):234-5. PubMed ID: 14965840 [Abstract] [Full Text] [Related]
5. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Elsharkawy MM, Youssef AM, Zayoon MY. Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745 [Abstract] [Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
7. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, Fusaroli M, Piazza V, Rapanà R, Strippoli GF. Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304 [Abstract] [Full Text] [Related]
13. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis. Flisiński M, Strózecki P, Stefańska A, Zarzycka-Lindner G, Brymora A, Manitius J. Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754 [Abstract] [Full Text] [Related]
14. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM. Am J Nephrol; 2008 Sep; 28(1):97-106. PubMed ID: 17914251 [Abstract] [Full Text] [Related]
19. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?]. Lovcić V, Kes P, Zeljko R, Kusec V. Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832 [Abstract] [Full Text] [Related]